Fill Your Pipelines Faster - Drug Discovery Partnerships in 2014
In recent years we have seen a slow but steady paradigm shift in how pharmaceutical companies approach early drug discovery. The role of discovery partnerships in a high-failure-rate industry such as bio/pharma is thus pivotal for enhancing innovation while de-risking in the pre-clinical stages. In this interview Kristof Van Emelen, Scientific Director - Partnership Integrator for Janssen Pharmaceutica N.V., speaks to Andrea Charles from Pharma IQ about impact of the rise of global innova...
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.